Notice of Registration - 2012
[Federal Register Volume 77, Number 246 (Friday, December 21, 2012)]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-30774]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances, Notice of Registration,
Halo Pharmaceutical, Inc.
By Notice dated July 30, 2012, and published in the Federal
Register on August 7, 2012, 77 FR 47114, Halo Pharmaceutical, Inc., 30
North Jefferson Road, Whippany, New Jersey 07981, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the following basic classes of controlled
Dihydromorphine is an intermediate in the manufacture of
Hydromorphone and is not for commercial distribution. The company plans
to manufacture Hydromorphone HCL for sale to other manufacturers, and
for the manufacture of other controlled substance dosage units for
distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a), and determined that the registration
of Halo Pharmaceutical, Inc., to manufacture the listed basic classes
of controlled substances is consistent with the public interest at this
time. DEA has investigated Halo Pharmaceutical, Inc., to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21
CFR 1301.33, the above named company is granted registration as a bulk
manufacturer of the basic classes of controlled substances listed.
Dated: December 14, 2012.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
[FR Doc. 2012-30774 Filed 12-20-12; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO).